GenMont Biotech Incorporation (3164.TW)

TWD 19.95

(-0.5%)

Annual Balance Sheets

(In TWD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 1.65 Billion 1.69 Billion 1.69 Billion 1.61 Billion 1.57 Billion 1.65 Billion
Total Current Assets 465.5 Million 521.5 Million 580.79 Million 595.94 Million 683.76 Million 1.11 Billion
Cash And Short Term Investments 328.3 Million 400.94 Million 421.72 Million 465.12 Million 526.47 Million 926.89 Million
Cash and Cash Equivalents 55.59 Million 133.68 Million 169.95 Million 274.84 Million 191.67 Million 225.29 Million
Short Term Investments 272.7 Million 267.25 Million 251.77 Million 190.28 Million 334.8 Million 701.6 Million
Net Receivables 40.02 Million 51.76 Million 55.06 Million 46.44 Million 72.01 Million 123.88 Million
Inventory 88.11 Million 55.3 Million 37.06 Million 34.78 Million 31.48 Million 40.46 Million
Other Current Assets 9.06 Million 13.49 Million 66.93 Million 49.58 Million 53.79 Million 146.38 Million
Total Non-Current Assets 1.18 Billion 1.17 Billion 1.11 Billion 1.01 Billion 887.39 Million 544.57 Million
Net PPE 1.06 Billion 1.11 Billion 1.05 Billion 922.68 Million 750.54 Million 352.68 Million
Good Will And Intangible Assets 2.25 Million 238 Thousand 333 Thousand 252 Thousand 116 Thousand 9.28 Million
Good Will - - - - - 8.94 Million
Intangible Assets 2.25 Million 238 Thousand 333 Thousand 252 Thousand 116 Thousand 341 Thousand
Long-Term Investments 72.22 Million -240.73 Million -217.09 Million -164.95 Million -302.51 Million -659.74 Million
Tax Assets 39.7 Million 22.72 Million 12.31 Million 7.76 Million 6.73 Million 7.07 Million
Other Non Current Assets 13.38 Million 278.84 Million 262.2 Million 251.13 Million 432.51 Million 835.27 Million
Other Assets - - - - - -
Total Liabilities 204.05 Million 198.59 Million 173.64 Million 130.95 Million 123.04 Million 95.6 Million
Total Current Liabilities 146.39 Million 160.77 Million 139.16 Million 94.95 Million 88.3 Million 91.76 Million
Account Payables 7.85 Million 14.36 Million 11.39 Million 7.38 Million 7.7 Million 7.5 Million
Tax Payables 18.95 Million 28.43 Million 33.82 Million 16.28 Million 14.19 Million 9.36 Million
Short Term Debt 4.59 Million 1.06 Million 2.11 Million 2.04 Million 1.57 Million 187 Thousand
Deferred Revenue 33.97 Million 25.75 Million 115.68 Million 79.66 Million 76.01 Million 9.36 Million
Other Current Liabilities 99.96 Million 119.59 Million 9.98 Million 5.86 Million 3.01 Million 74.71 Million
Total Non Current Liabilities 57.66 Million 37.81 Million 34.47 Million 35.99 Million 34.73 Million 3.84 Million
Long-Term Debt 20.11 Million 33.48 Million 30.62 Million 32.28 Million 31.08 Million -
Deferred Revenue Non Current 33.59 Million - - - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 2.36 Million 2.36 Million 2.31 Million 2.31 Million 2.31 Million 2.34 Million
Other Liabilities - - - - - -
Total Equity 1.44 Billion 1.49 Billion 1.52 Billion 1.48 Billion 1.44 Billion 1.56 Billion
Stock Holders Equity 1.31 Billion 1.35 Billion 1.37 Billion 1.32 Billion 1.38 Billion 1.49 Billion
Common Stock 865.11 Million 863.71 Million 863.71 Million 863.41 Million 889.34 Million 889.11 Million
Retained Earnings 89.96 Million 58.95 Million 113.99 Million 33.17 Million 107.33 Million 199.23 Million
Accumulated other comprehensive income -2.4 Million 67.78 Million 37.86 Million 61.25 Million 4.8 Million 19.36 Million
Common Stock Equity 1.31 Billion 1.35 Billion 1.37 Billion 1.32 Billion 1.38 Billion 1.49 Billion
Capital Lease Obligation 33.59 Million 34.54 Million 32.73 Million 34.33 Million 32.65 Million -
Total Investments 344.93 Million 26.52 Million 34.68 Million 25.33 Million 32.28 Million 41.85 Million
Total Debt 58.3 Million 34.54 Million 32.73 Million 34.33 Million 32.65 Million 187 Thousand
Net Debt 2.71 Million -99.14 Million -137.22 Million -240.51 Million -159.01 Million -225.1 Million

Balance Sheet Charts